Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42,998,448
-
Total 13F shares
-
41,311,639
-
Share change
-
+959,919
-
Total reported value
-
$1,572,292,288
-
Put/Call ratio
-
58%
-
Price per share
-
$38.06
-
Number of holders
-
203
-
Value change
-
+$29,425,330
-
Number of buys
-
107
-
Number of sells
-
94
Institutional Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q1 2019
As of 31 Mar 2019,
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) was held by
203 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,311,639 shares.
The largest 10 holders included
VANGUARD GROUP INC, Consonance Capital Management LP, BlackRock Inc., MACQUARIE GROUP LTD, FRONTIER CAPITAL MANAGEMENT CO LLC, Rock Springs Capital Management LP, Stephens Investment Management Group LLC, Clearbridge Investments, LLC, MILLENNIUM MANAGEMENT LLC, and ARMISTICE CAPITAL, LLC.
This page lists
203
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.